Perspective Therapeutics (CATX) Amortizatization of Intangibles (2010 - 2024)
Perspective Therapeutics (CATX) posted Amortizatization of Intangibles of $14000.0 for Q4 2023, up 55.56% sequentially from $9000.0 in Q3 2023, and down 17.65% YoY from $17000.0 in Q4 2022.
Perspective Therapeutics (CATX) Amortizatization of Intangibles (2010 - 2024) Analysis & Trends
Perspective Therapeutics has reported Amortizatization of Intangibles for 14 years, with the latest figure at $14000.0 in Q4 2023.
- Quarterly Amortizatization of Intangibles fell 17.65% year-over-year to $14000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $14000.0 (down 67.44% YoY) and the FY2023 annual result came in at $40000.0, up 21.21% from the prior year.
- Amortizatization of Intangibles grew to $14000.0 in Q4 2023 per CATX's latest filing, from $9000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $25000.0 in Q3 2022 and troughed at -$9000.0 in Q4 2021.
- A 5-year average of $10736.8 and a median of $10000.0 in 2020 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles sank 250.0% in 2021, then soared 288.89% in 2022.
- Over 5 years, Amortizatization of Intangibles stood at $13000.0 in 2019, then tumbled by 53.85% to $6000.0 in 2020, then tumbled by 250.0% to -$9000.0 in 2021, then jumped by 288.89% to $17000.0 in 2022, then retreated by 17.65% to $14000.0 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $14000.0, $9000.0, and $8000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Perspective Therapeutics | 396.34 Mn | 396.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |